B24 Ventures
News
Submit Deal
Add News
Expert Analysis
VCs
JD
Aastha Anand
aastha@b24ventures.com
News
Checking EventRegistry configuration...
Search News
Filter by Country
Select country...
IPO Calendar: Excelsoft to lead a quiet week as mainboard action slows, but listings galore
Economic Times
2025-11-15T08:16:14Z
dmoz/Business/Information Technology
dmoz/Business/Major Companies
dmoz/Business/Information Technology/Marketing and Advertising
Initial public offering
Indian rupee
IPO Calendar: Excelsoft to lead a quiet week as mainboard action slows, but listings galore
Economic Times
2025-11-15T08:16:14Z
dmoz/Business/Information Technology
dmoz/Business/Major Companies
dmoz/Business/Information Technology/Marketing and Advertising
Initial public offering
Indian rupee
IPO Calendar: Excelsoft to lead a quiet week as mainboard action slows, but listings galore
Economic Times
2025-11-15T08:16:14Z
dmoz/Business/Information Technology
dmoz/Business/Major Companies
dmoz/Business/Information Technology/Marketing and Advertising
Initial public offering
Indian rupee
IPO Calendar: Excelsoft to lead a quiet week as mainboard action slows, but listings galore
Economic Times
2025-11-15T08:16:14Z
dmoz/Business/Information Technology
dmoz/Business/Major Companies
dmoz/Business/Information Technology/Marketing and Advertising
Initial public offering
Indian rupee
Glenmark Pharma Q2 PAT climbs 72% YoY to Rs 610 cr
Business Standard
2025-11-15T08:16:26Z
dmoz/Business/Biotechnology and Pharmaceuticals
dmoz/Business/Biotechnology and Pharmaceuticals/Pharmaceuticals
dmoz/Business/Healthcare/Marketing and Advertising
Glenmark Pharmaceuticals
Earnings before interest, taxes, depreciation, and amortization
Glenmark Pharma Q2 PAT climbs 72% YoY to Rs 610 cr
Business Standard
2025-11-15T08:16:26Z
dmoz/Business/Biotechnology and Pharmaceuticals
dmoz/Business/Biotechnology and Pharmaceuticals/Pharmaceuticals
dmoz/Business/Healthcare/Marketing and Advertising
Glenmark Pharmaceuticals
Earnings before interest, taxes, depreciation, and amortization
Glenmark Pharma Q2 PAT climbs 72% YoY to Rs 610 cr
Business Standard
2025-11-15T08:16:26Z
dmoz/Business/Biotechnology and Pharmaceuticals
dmoz/Business/Biotechnology and Pharmaceuticals/Pharmaceuticals
dmoz/Business/Healthcare/Marketing and Advertising
Glenmark Pharmaceuticals
Earnings before interest, taxes, depreciation, and amortization
IITs see opportunity in Trump's H-1B curbs
MoneyControl
2025-11-15T08:18:31Z
dmoz/Society/Relationships
dmoz/Society/Relationships/Romance
Cookie
Accept (band)
Glenmark Pharma Q2 PAT climbs 72% YoY to Rs 610 cr
Business Standard
2025-11-15T08:16:26Z
dmoz/Business/Biotechnology and Pharmaceuticals
dmoz/Business/Biotechnology and Pharmaceuticals/Pharmaceuticals
dmoz/Business/Healthcare/Marketing and Advertising
Glenmark Pharmaceuticals
Earnings before interest, taxes, depreciation, and amortization
IITs see opportunity in Trump's H-1B curbs
MoneyControl
2025-11-15T08:18:31Z
dmoz/Society/Relationships
dmoz/Society/Relationships/Romance
Cookie
Accept (band)
Previous
Page 132 of 975
Next